DAS28 Rheumatoid Arthritis Score
Calculate DAS28-ESR or DAS28-CRP to assess rheumatoid arthritis disease activity and determine remission, low, moderate, or high activity status.
Use the DAS28 Rheumatoid Arthritis Score
DAS28 Inputs
0 = no activity, 100 = maximum activity
Enter values on the left and click Calculate DAS28 to see the score.
DAS28 Score
ESRClinical Interpretation
Formula Breakdown
EULAR Activity Thresholds
| Category | DAS28 Range | Meaning |
|---|---|---|
| Remission | < 2.6 | Conventional remission band |
| Low Activity | 2.6 – 3.2 | Conventional low-activity band |
| Moderate Activity | 3.2 – 5.1 | Conventional moderate-activity band |
| High Activity | > 5.1 | Conventional high-activity band |
Formula and interpretation sources
Summary
The DAS28 (Disease Activity Score in 28 joints) is a composite measure used to describe rheumatoid arthritis disease activity. This calculator implements the validated four-variable ESR and CRP formulas using tender and swollen 28-joint counts, an inflammatory marker, and a 0–100 mm patient global assessment. A score is one part of a clinician’s longitudinal assessment and is not a stand-alone treatment instruction.
How it works
- Select the variant: DAS28-ESR (uses erythrocyte sedimentation rate) or DAS28-CRP (uses C-reactive protein).
- Enter the 28 Tender Joint Count (TJC28) — the number of joints that are painful on pressure or passive movement.
- Enter the 28 Swollen Joint Count (SJC28) — the number of joints with soft-tissue swelling.
- Enter the ESR (mm/hr) or CRP (mg/L) laboratory value for the inflammatory marker.
- Enter the Patient Global Assessment (PGA) on a 0–100 mm visual analog scale (0 = no activity, 100 = maximum activity).
- Click Calculate to see the DAS28 score and EULAR disease activity category.
Use cases
- Monitor disease activity at each clinic visit for patients with rheumatoid arthritis.
- Record whether a calculated score falls below the conventional DAS28 remission threshold.
- Assess response to biologic or DMARD therapy using EULAR response criteria.
- Document disease burden for insurance authorization of biologic agents.
- Compare pre- and post-treatment scores to quantify therapeutic benefit.
- Support clinical trial enrollment and outcome reporting.
- Educate patients on their current disease activity level in a standardized way.
- Differentiate conventional low, moderate, and high activity bands for discussion with a clinician.